The She-conomy: Why Women's Health is the Next Trillion-Dollar Frontier

If you ever needed proof that passion and purpose are the most powerful fuels for innovation, the recent panel I attended on the future of women's health provided it in spades. The conversation wasn't just about medicine; it was about justice, data, and a multi-billion-dollar opportunity hiding in plain sight.

On Tuesday I went to an event in Central London hosted by Covington & Burling LLP and Nexus – a new app for women's health tracking. The panel brought together a formidable group: a pharmaceutical expert driven by her brother's epilepsy, a VC founder who traded her therapy practice for a $70 million "Revenge" fund, a tech founder motivated by his wife's and sister's diagnostic odysseys, a life sciences lawyer, and a researcher at the forefront of health AI.

Their personal stories illuminated a systemic failure. As one speaker starkly put it, the healthcare system—from clinical trials to AI algorithms—has been built on a default male model. The consequences are not just inconvenient; they are life-threatening.

The Invisible Patient: How We Got Here

The history is as shocking as it is recent. As one expert detailed, following the thalidomide disaster in the 1970s, the FDA essentially banned women of "childbearing potential" from clinical trials for nearly two decades. The assumption was that women were simply smaller men, and drug responses would be the same. This bias is baked into our foundational medical data.

This legacy persists today:

• Misdiagnosis: Women are more likely to be dismissed as "stressed" or "anxious" when presenting with symptoms, a phenomenon known as the "Yentl Syndrome."
• Glaring Inequity: Conditions like endometriosis and PCOS are severely under-researched and underfunded compared to male conditions like erectile dysfunction.
• Data Void: The very algorithms powering new health tech, including consumer tools like ChatGPT, are trained on this biased data, perpetuating the cycle of neglect.

Driving UK Startup Growth by Bridging the Gap

For UK startups, this isn't just a social imperative; it's the clearest growth map you could ask for. The insights from the panel point to three powerful strategies for innovation and scaling.

1. Go Deep, Not Just Broad: The Specialisation Advantage

The biggest mistake a startup can make in this space is trying to be everything to every woman. The problems are too nuanced. The successful companies identified by the panel are hyper-specialised:

• Cyclonica: Diagnosing endometriosis using menstrual fluid.
• Pexxi: A supplement specifically formulated for period pain.
• Ditto: Tackling postnatal care with a blended digital and physical model.

The Growth Lesson: Don't build another general wellness app. Identify a single, specific, and underserved condition—like incontinence, menopause-related frozen shoulder, or postnatal recovery—and own it completely. Depth beats breadth when you're correcting for decades of neglect.

2. Build Trust by Building Community and Clinical Rigour

A powerful question from the audience highlighted a critical challenge: how do you reach women who are distrustful of the healthcare system? The answer lies in community and evidence.

• Community as a Channel: Trust often lies with local charities, religious groups, and grassroots organisations, not with large institutions. Startups that partner with these trusted entities can build credibility and reach "hard-to-reach" users authentically.
• Clinical Rigour as a Moat: Robust data is your differentiator. Utilise the UK's innovation grants to fund proper clinical trials before you seek major venture funding.

The Growth Lesson: Your marketing strategy should be community-first, and your product strategy should be evidence-first. This builds a loyal user base and a defensible market position that investors will fight to back.

3. Master the "Why": The Unfair Advantage of User Research & Behavioural Science

A great medical solution can fail if it doesn't account for the real-world user. This is where deep user research and behavioural science become a startup's unfair advantage.

Women's health is fraught with taboos, fatigue from the "care cycle," and complex daily routines. Simply providing information is not enough. Startups must ask:

• What are the unspoken barriers? Is it shame? Is it time poverty? Is it a lifetime of being dismissed that has led to a "why bother?" attitude?
• How can we design for action? Can you use nudges to help a sleep-deprived new mother remember her supplements? Can you use gamification to make tracking symptoms feel empowering rather than burdensome?

The Growth Lesson: Integrate user researchers and behavioural scientists from day one. By understanding the emotional and behavioural context of your users, you can design products that people not only need but will actually use and love.

4. Turn the AI Bias into Your USP

The discussion on AI was a wake-up call. Off-the-shelf large language models (LLMs) are riddled with the gender data gap, often "hallucinating" or providing biased responses when asked about women's health.

One start-up tackled this not by using a generic AI, but by building its own from the ground up. They trained their model on a proprietary corpus of peer-reviewed women's health research and user data, ensuring both accuracy and privacy.

The Growth Lesson: Don't just use AI; build your AI. In a world of biased algorithms, a specialised, accurately trained model isn't just a feature—it's your entire unique selling proposition (USP).

A Call to Action: The Power of the Ecosystem

The final, crucial insight was about allyship. The room, though passionate, needed more men.

The growth of the UK's women's health ecosystem depends on this. It requires:

• Founders to specialise, validate, and deeply understand their users' behaviours.
• Investors to look beyond conventional sectors, fund with conviction, and value behavioural insights as a key metric for success.
• Consumers to support and champion these new solutions.
• Allies to amplify the conversation and demand change.

The UK has the talent, the research institutions, and a growing sense of urgency. The blueprint for innovation is clear. It's time to stop building for a world that doesn't exist and start innovating for the one that does—a world where women's health is not an afterthought, but the cornerstone of a healthier, and more prosperous, society for all.

An Afterthought: The Coder's Bias

As we build this new future, there's a foundational layer we cannot ignore: who is writing the code? The AI bias problem isn't just about the data going in; it's also about the perspectives of the architects building the systems.

Algorithms are not neutral. They are shaped by the assumptions, experiences, and blind spots of their creators. When a discipline is homogenous—as tech and coding have historically been—those blind spots become embedded in the technology itself.

Bringing more women into software engineering, data science, and AI development isn't just a diversity initiative; it's a critical step in the quality assurance process. It is a fundamental method for debugging bias at the source. By diversifying the teams that build our technological future, we don't just create fairer algorithms for women's health; we build smarter, more robust, and more accurate systems for everyone.